Bone Marrow Transplantation

Top Story

Monthly cost of oral cancer drugs rises steadily over time

Monthly cost of oral cancer drugs rises steadily over time
April 28, 2016

The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA Oncology.

High drug prices can affect patient adherence to cancer therapies and increase the financial burden of medical care, according to Stacie B. Dusetzina, PhD, assistant professor of pharmaceutical outcomes and policy at University of North Carolina Eshelman School of Pharmacy.

In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder —…
Meeting News Coverage

Biden: Realignment of research incentives key to cancer moonshot initiative

April 20, 2016
A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice President Joe Biden said…
Meeting News Coverage

AACR presents several scientific awards

April 17, 2016
NEW ORLEANS The American Association for Cancer Research will recognize several clinicians and researchers during its annual meeting. Sir Richard S. Peto
CME

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
Video
Meeting News Coverage

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder

April 27, 2015
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter…
In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment…
Meeting News Coverage

Biden: Realignment of research incentives key to cancer moonshot initiative

April 20, 2016
A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice…
Meeting News Coverage

AACR presents several scientific awards

April 17, 2016
NEW ORLEANS The American Association for Cancer Research will recognize several clinicians and researchers during its annual meeting. Sir
In the JournalsPerspective

HSCT may improve DFS, OS in older patients with AML

April 15, 2016
Reduced-intensity conditioning hematopoietic stem cell transplantation appeared well tolerated and associated with favorable outcomes in selected…
Meeting News Coverage

AACR Annual Meeting begins this weekend

April 14, 2016
NEW ORLEANS — The HemOnc Today and Healio.com/HemOnc team will present comprehensive live coverage from the American Association for Cancer…
In the Journals

Reduced-intensity allogeneic transplant effective salvage therapy in follicular lymphoma

April 4, 2016
Patients with follicular lymphoma who experienced disease recurrence after autologous stem cell transplant demonstrated benefit from…

ASCO to honor researchers, scientists at annual meeting

April 1, 2016
ASCO will recognize several researchers and scientists during the society’s annual meeting, scheduled for June 3-7 in Chicago.“The…
FDA News

FDA approves Defitelio to treat hepatic VOD, multiorgan dysfunction after HSCT

March 30, 2016
The FDA today approved defibrotide sodium to treat adults and children who developed hepatic veno-occlusive disease with renal and pulmonary…

ASCO names new CEO

March 23, 2016
Clifford A. Hudis, MD, FACP, has been named the next CEO of ASCO.Hudis currently serves as chief of the breast medicine service, vice president for…
More Headlines »
morganatic-roan